Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
Jun 17 NVO Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs
Jun 17 ADMA ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Could Be 36% Below Their Intrinsic Value Estimate
Jun 17 NVO Could Structure Therapeutics Become the Next Novo Nordisk?
Jun 17 NVO Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
Jun 16 RNA Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
Jun 16 NVO Ozempic drives more demand for smaller clothes, WSJ reports
Jun 16 REGN Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
Jun 16 MREO Street calls of the week: Upgrade for Shopify; downgrades for AMD, Paramount
Jun 15 NVO U.S. drug shortages worsen to reach a decade high: report
Jun 15 NVO Novo Nordisk CEO to testify before Senate on Ozempic pricing
Jun 15 NVO 3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Jun 14 NVO Employee benefits survey finds marked increase in GLP-1 coverage
Jun 14 NVO Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors
Jun 14 NVO Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
Jun 14 NVO Eli Lilly unveils new manufacturing plant for GLP-1 pens
Jun 14 NVO IBD Sector Leaders: Top Picks To Watch Include Nvidia Stock, Ozempic Maker Novo Nordisk
Jun 14 REGN Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea
Jun 14 NVO Few IBD 50 Stocks In Buy Zones; Netflix Is One
Jun 14 RNA Avidity Biosciences: Muscular Dystrophy Breakthrough Propels To A 'Buy' Upgrade
Jun 14 REGN Regeneron wins injunction blocking Samsung Bioepis from launching generic Eylea
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags